For stable narrow‑complex supraventricular tachycardia, is adenosine or diltiazem preferred as first‑line therapy, and what are the contraindications for each?

Adenosine vs Diltiazem for Stable Narrow-Complex SVT

Adenosine is the preferred first-line pharmacological agent for stable narrow-complex supraventricular tachycardia after vagal maneuvers, with a Class I recommendation and approximately 95% conversion rate, while diltiazem is a reasonable alternative (Class IIa) particularly useful for patients who fail adenosine or experience recurrence. 1

Treatment Algorithm

First-Line Approach

• Vagal maneuvers should be attempted first (Class I recommendation), including Valsalva maneuver (bearing down against closed glottis for 10-30 seconds at 30-40 mmHg) or carotid sinus massage (5-10 seconds after confirming absence of bruit) 1
• If vagal maneuvers fail, adenosine is the recommended next step (Class I, Level B-R evidence) with conversion rates of 78-96% for AVNRT and AVRT 1

Adenosine Administration

• Administer as rapid IV bolus via proximal vein followed immediately by saline flush 1
• Initial dose: 6 mg, followed by 12 mg if needed, then second 12 mg dose 2
• Response occurs within 3 minutes, with maximal effect in 2-7 minutes 3
• Continuous ECG recording during administration helps distinguish true failure from successful termination with immediate reinitiation 1

Alternative: Diltiazem

• Diltiazem or verapamil are reasonable alternatives (Class IIa, Level B-R) with conversion rates of 64-98% 1
• Particularly useful when:
  • Adenosine fails or causes recurrence 1
  • Patient cannot tolerate adenosine side effects 4
  • Visible retrograde P-waves or aVL notch present on ECG 2
• Dosing: 0.25 mg/kg IV (typically 15-20 mg) 2
• Administer slowly over up to 20 minutes to minimize hypotension risk 1, 4

Key Contraindications

Adenosine Contraindications

• Second- or third-degree AV block (without pacemaker)
• Sick sinus syndrome (without pacemaker)
• Severe bronchospasm or active asthma exacerbation
• Known hypersensitivity

Diltiazem Contraindications (Critical)

• Sick sinus syndrome without functioning pacemaker 3
• Second- or third-degree AV block without pacemaker 3
• Severe hypotension or cardiogenic shock 3
• Suspected systolic heart failure 1
• Pre-excited atrial fibrillation/flutter (WPW syndrome, accessory pathway) - can cause life-threatening ventricular rate acceleration and ventricular fibrillation 3
• Wide-complex tachycardia (QRS ≥0.12 seconds) - must confirm supraventricular origin before administration 3
• Ventricular tachycardia - can cause hemodynamic deterioration and ventricular fibrillation 3
• Cannot be given concurrently or within hours of IV beta-blockers 3

Comparative Efficacy Data

Conversion Rates

• Adenosine: 78-96% success rate, with AVNRT conversion approximately 95% 1
• Diltiazem: 64-98% success rate 1
• Recent multicenter study showed 82.4% conversion with diltiazem vs 66.8% with adenosine (not statistically significant, p=0.08) 5

Time to Conversion

• Adenosine: Median 3 minutes to conversion 5
• Diltiazem: Median 6 minutes to conversion 5

Rescue Therapy

• Diltiazem successfully rescued 35% of cases that failed adenosine monotherapy 5
• Diltiazem also controlled 77% of conversions to atrial fibrillation/flutter without hypotensive events 5

Side Effect Profile

Adenosine

• More frequent minor adverse effects: chest discomfort, shortness of breath, flushing, sense of impending doom 1, 4
• Effects are short-lived due to very short half-life (seconds) 1
• Higher rate of arrhythmia re-initiation compared to calcium channel blockers 6
• Serious adverse effects are rare 1

Diltiazem

• Longer duration of action (effects may last 0.5 to >10 hours after infusion) 3
• Risk of hypotension if given too rapidly - mitigated by slow infusion over 20 minutes 1, 4
• Significantly fewer minor side effects compared to adenosine 4
• In clinical trials, only 3.2% required intervention for blood pressure support 3

Clinical Pitfalls to Avoid

1. Never give diltiazem/verapamil if pre-excitation suspected - look for delta waves, short PR interval, or wide QRS in sinus rhythm indicating accessory pathway 3

2. Ensure accurate diagnosis before diltiazem - must distinguish wide-complex SVT from ventricular tachycardia, as misdiagnosis can be fatal 3

3. Avoid diltiazem in heart failure - can worsen hemodynamics in patients with systolic dysfunction 1

4. Do not combine IV diltiazem with IV beta-blockers - contraindicated within hours of each other 3

5. Adenosine administration technique matters - must use proximal IV with rapid push followed immediately by saline flush for effectiveness 1

Hemodynamically Unstable Patients

• Synchronized cardioversion is recommended (Class I) when adenosine and vagal maneuvers fail or are not feasible 1
• Adenosine may be attempted first if tachycardia is regular with narrow QRS complex, even in unstable patients 1
• Recent data suggests adenosine may be safe as first-line attempt before cardioversion in unstable patients, potentially reducing sedation-related risks 7